Basic Information
| LncRNA/CircRNA Name | circ_0001667 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR |
| Sample | breast cancer tissues and cell lines |
| Expression Pattern | up-regulated |
| Function Description | circ_0001667 was overexpressed in breast cancer tissues or cell lines compared to the adjacent normal tissues or normal cells. There was a negative relationship between circ_0001667 levels and the life time of breast cancer patients. Meanwhile, the inhibition of circ_0001667 suppressed the proliferation and metastasis of human breast cancer cells. |
| Pubmed ID | 31893023 |
| Year | 2020 |
| Title | Circ_0001667 promotes breast cancer cell proliferation and survival via Hippo signal pathway by regulating TAZ |
External Links
| Links for circ_0001667 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |